PL2854794T3 - Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy - Google Patents

Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy

Info

Publication number
PL2854794T3
PL2854794T3 PL13725972T PL13725972T PL2854794T3 PL 2854794 T3 PL2854794 T3 PL 2854794T3 PL 13725972 T PL13725972 T PL 13725972T PL 13725972 T PL13725972 T PL 13725972T PL 2854794 T3 PL2854794 T3 PL 2854794T3
Authority
PL
Poland
Prior art keywords
granules containing
glyceryl trinitrate
containing glyceryl
stabilized granules
inducing arteriogenesis
Prior art date
Application number
PL13725972T
Other languages
English (en)
Inventor
Michaela Gorath
Original Assignee
G Pohl Boskamp Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by G Pohl Boskamp Gmbh & Co Kg filed Critical G Pohl Boskamp Gmbh & Co Kg
Publication of PL2854794T3 publication Critical patent/PL2854794T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL13725972T 2012-05-31 2013-05-29 Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy PL2854794T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261653601P 2012-05-31 2012-05-31
EP12004188.4A EP2668948A1 (en) 2012-05-31 2012-05-31 Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
EP13725972.7A EP2854794B1 (en) 2012-05-31 2013-05-29 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis
PCT/EP2013/061128 WO2013178713A1 (en) 2012-05-31 2013-05-29 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis

Publications (1)

Publication Number Publication Date
PL2854794T3 true PL2854794T3 (pl) 2019-04-30

Family

ID=46275672

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13725972T PL2854794T3 (pl) 2012-05-31 2013-05-29 Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy

Country Status (5)

Country Link
EP (3) EP2668948A1 (pl)
ES (1) ES2704649T3 (pl)
PL (1) PL2854794T3 (pl)
TR (1) TR201820481T4 (pl)
WO (1) WO2013178713A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE033092T2 (hu) 2012-05-31 2017-11-28 G Pohl-Boskamp Gmbh & Co Kg Arteriogenezis indukálása nitroglicerinnel mint nitrogén-oxid donorral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE209911T1 (de) * 1997-10-03 2001-12-15 Warner Lambert Co Gepresste nitroglycerintablette und verfahren zu ihrer herstellung
DE102008005484A1 (de) * 2008-01-22 2009-07-23 Schaper, Wolfgang, Dr. Induktion und Förderung der Arteriogenese
US20120059245A1 (en) 2008-12-23 2012-03-08 Ivo Buschmann Method and device for monitoring and improving arteriogenesis

Also Published As

Publication number Publication date
EP3482757A1 (en) 2019-05-15
TR201820481T4 (tr) 2019-01-21
ES2704649T3 (es) 2019-03-19
EP2854794A1 (en) 2015-04-08
WO2013178713A1 (en) 2013-12-05
EP2854794B1 (en) 2018-10-10
EP2668948A1 (en) 2013-12-04

Similar Documents

Publication Publication Date Title
HK1216008A1 (zh) 穩定的萬古黴素製劑
IL233482A0 (en) Stabilized formulations that include anti-ang2 antibodies
HK1201735A1 (en) Robust controlled-release formulations
EP2696784A4 (en) SPINAL STABILIZATION
HK1204973A1 (en) Diclofenac formulations
PL2877155T3 (pl) Formulacje opioidowe
SG11201405578TA (en) Pharmaceutical composition containing peptide
ZA201504003B (en) Stabilizing system
HK1204961A1 (en) Solid pharmaeutical preparation containing levothyroxine
HK1207305A1 (en) Stabilized formulations containing anti-dll4 antibodies -dll4
IL289157A (en) Opioid compounds
EP2729164A4 (en) FORMULATIONS STABILIZING PROTEINS
PT2908835T (pt) Formulações estáveis
EP2885325A4 (en) CURABLE POLYACRYLATES IN THE PRESENCE OF MOISTURE
PL2678000T3 (pl) Stabilizowane granulaty zawierające triazotan glicerolu
PL2854794T3 (pl) Stabilizowane granulki zawierające triazotan glicerylu do wywoływania arteriogenezy
EP2835173A4 (en) PLANAR'S BIOFILTRATION SYSTEM
ZA201404909B (en) Stabilized formulations containing anti-ang2 antibodies
ZA201405168B (en) Support for facets
GB201215324D0 (en) Improved deluge system
GB201212600D0 (en) Bongo
HUP1000302A2 (en) Dedicated dissolvent